Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Scancell and ImmunID to use ImmunTraCkeR to predict response to SCIB-1

July 31, 2015

FDA clears KaloBios' IND for KB-003 for chronic myelomonocytic leukemia

July 30, 2015

Inovio Pharmaceuticals begins trial of INO-5150 for prostate cancer

July 30, 2015

Fujifilm Kyowa Kirin Biologics establishes joint venture with AstraZeneca

July 29, 2015

Horizon collaborates with Fox Chase to study Actimmune with PD-1/PD-L1 inhibitors for cancer

July 29, 2015

TapImmune exercises option agreement for folate receptor alpha vaccine technology

July 28, 2015

EMA grants accelerated assessment to MAA for elotuzumab in MM

July 28, 2015

Inovio and EORTC to conduct phase II trial of INO-3112 in cervical cancer

July 24, 2015

Novartis files sBLA for ofatumumab as maintenance therapy for relapsed CLL

July 23, 2015

Merck & Co.'s Keytruda approved in Europe for advanced melanoma

July 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...